Definition and diagnosis of cesarean scar ectopic pregnancies.


Journal

Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 01 04 2023
revised: 10 05 2023
accepted: 14 05 2023
medline: 11 7 2023
pubmed: 25 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

Cesarean scar ectopic pregnancy is a rare type of ectopic pregnancy, where the pregnancy implants into a myometrial defect caused by a cesarean scar. Its incidence is predicted to increase, given the global increase in cesarean deliveries. As most cesarean scar ectopic pregnancies present as failing pregnancies or patients choose termination of pregnancy, there are limited data on their natural history. However, early first trimester diagnosis is essential, given the associated significant maternal morbidity. Transvaginal sonography is generally considered to be the optimal method for diagnosing cesarean scar ectopic pregnancy. There is no evidence that MRI adds to the diagnostic accuracy, and it is therefore not recommended for routine evaluation of cesarean scar ectopic pregnancy. There is no agreed reference standard for the diagnosis of cesarean scar ectopic pregnancy; therefore, the validity of several proposed sonographic diagnostic criteria reported by different authors remains unknown. There are also various suggested classification systems for cesarean scar ectopic pregnancy, which divide them in differet types. However, the proposals are very heterogeneous, and superiority of one classification system over another is yet to be established.

Identifiants

pubmed: 37356119
pii: S1521-6934(23)00067-6
doi: 10.1016/j.bpobgyn.2023.102360
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102360

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no conflict of interest.

Auteurs

Simrit Nijjar (S)

EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London (UCL), London, UK. Electronic address: simrit.nijjar@nhs.net.

Eric Jauniaux (E)

EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London (UCL), London, UK. Electronic address: e.jauniaux@ucl.ac.uk.

Davor Jurkovic (D)

EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London (UCL), London, UK. Electronic address: davor.jurkovic@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH